LIFE EXPERIENCES

Brand Owner (click to sort) Address Description
BEYOND THE ULTIMATE Campus Crusade for Christ, Inc. Attn: General Counsel's Office IP Team
100 Lake Hart Drive-3500
Orlando FL 328320100
Entertainment and educational services, providing on-line ...
BEYOND THE ULTIMATE Campus Crusade for Christ, Inc. Attn: General Counsel's Office IP Team
100 Lake Hart Drive-3500
Orlando FL 328320100
Paper goods and printed matter, devotional ...
DOING BAD FOR GOOD GRUDGR, LLC 5419 Hollywood Blvd., Suite C829
Los Angeles CA 90027
Providing online journals, blogs featuring commentary ...
EVERYATHLETE Campus Crusade for Christ, Inc. Attn: General Counsel's Office IP Team
100 Lake Hart Drive-3500
Orlando FL 328320100
Entertainment and educational services, providing a ...
G G GRUDGR, LLC 5419 Hollywood Blvd., Suite C829
Los Angeles CA 90027
Providing online journals, blogs featuring commentary ...
G GRUDGR DOING BAD FOR GOOD GRUDGR, LLC 5419 Hollywood Blvd., Suite C829
Los Angeles CA 90027
Providing online journals, blogs featuring commentary ...
GRUDGR GRUDGR, LLC 5419 Hollywood Blvd., Suite C829
Los Angeles CA 90027
Providing online journals, blogs featuring commentary ...
LIFE.0 Pasqua, Nicholas Apt 7
709 Palm Ave
Huntington Beach CA 92648
On-line journals, blogs featuring inspiration, motivation, ...
VIRTUAL GURU Franklin, Patricia 190 Del Mar Shores, Unit 69
Solano Beach CA 92075
Education services, providing recorded interviews in ...
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy. In one aspect, these compositions and methods provide a lower plasma concentration of oxybutynin metabolites, such as N-desethyloxybutynin, which is presumed to be contributing at least in part to some of the adverse drug experiences, while maintaining sufficient oxybutynin plasma concentration to benefit a subject with oxybutynin therapy. The invention also provides isomers of oxybutynin and its metabolites that meet these characteristics of minimized incidence and/or severity of adverse drug experiences, and maintenance of beneficial and effective therapy for overactive bladder. In some aspects, the composition may be presented in the form of an unoccluded or free form topically administered gel.